Sfoglia per Rivista ESMO OPEN
Isatuximab plus atezolizumab in patients with advanced solid tumors: results from a phase I/II, open-label, multicenter study
2022-01-01 Simonelli, M; Garralda, E; Eskens, F; Gil-Martin, M; Yen, C-J; Obermannova, R; Chao, Y; Lonardi, S; Melichar, B; Moreno, V; Yu, M-L; Bongiovanni, A; Calvo, E; Rottey, S; Machiels, J-P; Gonzalez-Martin, A; Paz-Ares, L; Chang, C-L; Mason, W; Lin, C-C; Reardon, D A; Vieito, M; Santoro, A; Meng, R; Abbadessa, G; Menas, F; Lee, H; Liu, Q; Combeau, C; Ternes, N; Ziti-Ljajic, S; Massard, C
Management of orphan symptoms: ESMO Clinical Practice Guidelines for diagnosis and treatment †
2020-01-01 Santini, D.; Armento, G.; Giusti, R.; Ferrara, M.; Moro, C.; Fulfaro, F.; Bossi, P.; Arena, F.; Ripamonti, C. I.
Nutrition in patients with cancer: A new area for medical oncologists? A practising oncologist's interdisciplinary position paper
2018-01-01 Rauh, S.; Antonuzzo, A.; Bossi, P.; Eckert, R.; Fallon, M.; Frobe, A.; Gonella, S.; Giusti, R.; Lakatos, G.; Santini, D.; Villarini, A.
Prognostic Nutritional Index: An easy nutritional screening for patients with head and neck cancer?
2018-01-01 Bossi, P.
Role of molecular genetics in the clinical management of cholangiocarcinoma
2022-01-01 Normanno, N; Martinelli, E; Melisi, D; Pinto, C; Rimassa, L; Santini, D; Scarpa, A
Safety and immunogenicity of the PRAME cancer immunotherapeutic in metastatic melanoma: results of a phase I dose escalation study
2016-01-01 Gutzmer, R; Rivoltini, L; Levchenko, E; Testori, A; Utikal, J; Ascierto, Pa; Demidov, L; Grob, Jj; Ridolfi, R; Schadendorf, D; Queirolo, P; Santoro, A; Loquai, C; Dreno, B; Hauschild, A; Schultz, E; Lesimple, Tp; Vanhoutte, N; Salaun, B; Gillet, M; Jarnjak, S; De Sousa Alves, Pm; Louahed, J; Brichard, Vg; Lehmann, Ff
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Isatuximab plus atezolizumab in patients with advanced solid tumors: results from a phase I/II, open-label, multicenter study | 1-gen-2022 | Simonelli, M; Garralda, E; Eskens, F; Gil-Martin, M; Yen, C-J; Obermannova, R; Chao, Y; Lonardi, S; Melichar, B; Moreno, V; Yu, M-L; Bongiovanni, A; Calvo, E; Rottey, S; Machiels, J-P; Gonzalez-Martin, A; Paz-Ares, L; Chang, C-L; Mason, W; Lin, C-C; Reardon, D A; Vieito, M; Santoro, A; Meng, R; Abbadessa, G; Menas, F; Lee, H; Liu, Q; Combeau, C; Ternes, N; Ziti-Ljajic, S; Massard, C | |
Management of orphan symptoms: ESMO Clinical Practice Guidelines for diagnosis and treatment † | 1-gen-2020 | Santini, D.; Armento, G.; Giusti, R.; Ferrara, M.; Moro, C.; Fulfaro, F.; Bossi, P.; Arena, F.; Ripamonti, C. I. | |
Nutrition in patients with cancer: A new area for medical oncologists? A practising oncologist's interdisciplinary position paper | 1-gen-2018 | Rauh, S.; Antonuzzo, A.; Bossi, P.; Eckert, R.; Fallon, M.; Frobe, A.; Gonella, S.; Giusti, R.; Lakatos, G.; Santini, D.; Villarini, A. | |
Prognostic Nutritional Index: An easy nutritional screening for patients with head and neck cancer? | 1-gen-2018 | Bossi, P. | |
Role of molecular genetics in the clinical management of cholangiocarcinoma | 1-gen-2022 | Normanno, N; Martinelli, E; Melisi, D; Pinto, C; Rimassa, L; Santini, D; Scarpa, A | |
Safety and immunogenicity of the PRAME cancer immunotherapeutic in metastatic melanoma: results of a phase I dose escalation study | 1-gen-2016 | Gutzmer, R; Rivoltini, L; Levchenko, E; Testori, A; Utikal, J; Ascierto, Pa; Demidov, L; Grob, Jj; Ridolfi, R; Schadendorf, D; Queirolo, P; Santoro, A; Loquai, C; Dreno, B; Hauschild, A; Schultz, E; Lesimple, Tp; Vanhoutte, N; Salaun, B; Gillet, M; Jarnjak, S; De Sousa Alves, Pm; Louahed, J; Brichard, Vg; Lehmann, Ff |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile